• Earnings Per Share (EPS) of $0.96, beating the estimated $0.92 and marking an 11.5% increase from the previous year.
• Revenue Growth: Achieved approximately $1.002 billion, surpassing the estimated $995.3 million, a 6.3% increase from the previous year.
• Financial Metrics: Price-to-Earnings (P/E) ratio of 33.07 and a Price-to-Sales ratio of 3.48, with a debt-to-equity ratio of 0.31.

The Cooper Companies, Inc. (NASDAQ:COO) is a leading entity in the Zacks Medical - Dental Supplies industry, specializing in products for contact lenses and women's health. Its divisions, CooperVision and CooperSurgical, are significant revenue contributors.

On May 29, 2025, COO reported an EPS of $0.96, surpassing the estimated $0.92. This represents an 11.5% increase from the previous year, as highlighted by Zacks. The company's non-GAAP EPS rose by 14% to $0.96, an increase of $0.11 from the same period last year.

COO achieved a revenue of approximately $1.002 billion, exceeding the estimated $995.3 million. This marks a 6.3% increase from the previous year. CooperVision saw a 5% rise in revenue to $669.6 million, while CooperSurgical experienced an 8% increase, reaching $332.7 million.

Despite these positive results, COO's stock declined by 4.9% in after-hours trading on May 29. The company tightened its sales outlook for 2025, which may have contributed to the stock's decline. Over the past four quarters, COO has exceeded consensus EPS estimates three times.

COO's financial metrics include a Price-to-Earnings (P/E) ratio of 33.07 and a Price-to-Sales ratio of 3.48. The debt-to-equity ratio is 0.31, indicating a moderate level of debt compared to equity. The current ratio is nearly 1.99, suggesting a strong ability to cover short-term liabilities.